Top-News

Sierra Oncology News

Aktie
WKN:  A2PYVV ISIN:  US82640U4040 US-Symbol:  SRRA
Keine aktuellen Kursdaten verfügbar
15.09.22 11:06:10
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
15,05 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 27.01.2022

Sierra Oncology News

03.05.22 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CMPI, SBOW, SRRA, ATRS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CMPI, SBOW, SRRA, ATRS PR Newswire
28.04.22 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds SRRA, HBP, EMCF, and VWTR Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds SRRA, HBP, EMCF, and VWTR Shareholders About Its Ongoing Investigations PR Newswire
28.04.22 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates PLAN, WAVD, SRRA, ATRS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates PLAN, WAVD, SRRA, ATRS PR Newswire
20.04.22 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds ATRS, SRRA, HBP, and EMCF Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds ATRS, SRRA, HBP, and EMCF Shareholders About Its Ongoing Investigations PR Newswire
18.04.22 - PR Newswire
Investor Alert - The M&A Class Action Firm is Investigating the Merger - ATRS, SRRA, SAIL, MSP, CDK, VWTR
Investor Alert - The M&A Class Action Firm is Investigating the Merger - ATRS, SRRA, SAIL, MSP, CDK, VWTR PR Newswire
13.04.22 - Der Aktionär
Übernahme‑Doppelschlag am Mittwoch – Biotech‑Branche vor großem Comeback?
13.04.22 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Investigates Sierra Oncology, Inc.
SHAREHOLDER ALERT: Weiss Law Investigates Sierra Oncology, Inc. PR Newswire
13.04.22 - PR Newswire
Thinking about buying stock in Alzamend Neuro, Briacell Therapeutics, Sierra Oncology, Artelo Biosciences, or Veru?
Thinking about buying stock in Alzamend Neuro, Briacell Therapeutics, Sierra Oncology, Artelo Biosciences, or Veru? PR Newswire
13.04.22 - Der Aktionär
Milliarden‑Deal! Dividenden‑Garant GlaxoSmithKline will Sierra Oncology – Übernahmekarussell nimmt Fahrt auf
08.02.22 - PR Newswire
Thinking about buying stock in GrowGeneration, Teradata, Spirit Airlines, Deutsche Bank, or Sierra Oncology?
Thinking about buying stock in GrowGeneration, Teradata, Spirit Airlines, Deutsche Bank, or Sierra Oncology? PR Newswire
27.01.22 - PR Newswire
Thinking about buying stock in Sierra Oncology, ShiftPixy, Sasol, MarineMax, or Ion Geophysical?
Thinking about buying stock in Sierra Oncology, ShiftPixy, Sasol, MarineMax, or Ion Geophysical? PR Newswire
25.01.22 - PR Newswire
Thinking about buying stock in Sierra Oncology, Allscripts Healthcare Solutions, SmileDirectClub, Ericsson, or Amarin Corp?
Thinking about buying stock in Sierra Oncology, Allscripts Healthcare Solutions, SmileDirectClub, Ericsson, or Amarin Corp? PR Newswire
23.06.21 - PR Newswire
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
21.06.21 - PR Newswire
Sierra Oncology Announces Completion of Enrollment for MOMENTUM Phase 3 Trial
Sierra Oncology Announces Completion of Enrollment for MOMENTUM Phase 3 Trial PR Newswire
14.06.21 - PR Newswire
Sierra Oncology Hosting KOL Panel Event to Discuss Momelotinib Data Presented at EHA 2021
Sierra Oncology Hosting KOL Panel Event to Discuss Momelotinib Data Presented at EHA 2021 PR Newswire
11.06.21 - PR Newswire
Momelotinib Oral Presentation at European Hematology Association Demonstrates Association Between Transfusion Independence and Improved Overall Survival
Momelotinib Oral Presentation at European Hematology Association Demonstrates Association Between Transfusion Independence and Improved Overall Survival PR Newswire
03.06.21 - PR Newswire
Sierra Oncology Welcomes Two New Independent Directors to its Board
Sierra Oncology Welcomes Two New Independent Directors to its Board PR Newswire
25.05.21 - PR Newswire
Sierra Oncology Announces Presentation at Jefferies Healthcare Conference
Sierra Oncology Announces Presentation at Jefferies Healthcare Conference PR Newswire
21.05.21 - PR Newswire
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
19.05.21 - PR Newswire
Sierra Oncology Announces Abstracts Accepted for American Society of Clinical Oncology Annual Meeting
Sierra Oncology Announces Abstracts Accepted for American Society of Clinical Oncology Annual Meeting PR Newswire

Newssuche

Videos

newspaper
08:55 Uhr +11,95%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »